QURE
uniQure N.V. - Ordinary Shares (QURE)
$31
About uniQure N.V. - Ordinary Shares (QURE)
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.
Details
Daily high
$45.02
Daily low
$43.81
Price at open
$44.50
52 Week High
$71.50
52 Week Low
$8.73
Market cap
3.1B
Dividend yield
-
Volume
801,233
Avg. volume
1.3M
P/E ratio
-10.87
uniQure N.V. - Ordinary Shares News
Details
Daily high
$45.02
Daily low
$43.81
Price at open
$44.50
52 Week High
$71.50
52 Week Low
$8.73
Market cap
3.1B
Dividend yield
-
Volume
801,233
Avg. volume
1.3M
P/E ratio
-10.87